Shifting Toward Sustainable Reimbursement Model...

By João L. Carapinha

November 4, 2025

Escaping Fee-for-Service: Pathways to Sustainable Reimbursement Models The Council for Medic...
Medical Schemes Affordability Crisis: Insights from the CMS Annual Report 202...
Aligning Medical Schemes with National Health Insurance South Africa
Rethinking Health Technology Assessment: Evolving Economic Evaluations for Fa...
PhRMA’s Patient Access Investment: $500 Billion Commitment to Domestic ...
Sanofi Insulin Savings: Your Comprehensive Guide for 2025
NHS Productivity Gains at Risk: Balancing Innovation and Cost Control
Medicare ACO Outcomes: Balancing Surgical Benefits and Costs Under the TEAM M...
Collaboration Cardiac Surgery: Boosting Surgical Volumes Through Multidiscipl...
Key Decisions on Health Technology Assessment at ACP124: Implications for Rar...
Rare Medications Coverage in the Netherlands: Price Reductions Required
Most Expensive Drugs 2025: Trends and Implications in US Pharma Pricing
Navigating Challenges for Small Countries to Access Innovative Medicines